Eric Martel

980 total citations
39 papers, 676 citations indexed

About

Eric Martel is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Eric Martel has authored 39 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 5 papers in Biomedical Engineering. Recurrent topics in Eric Martel's work include Cardiac electrophysiology and arrhythmias (16 papers), Heart Rate Variability and Autonomic Control (11 papers) and Ion channel regulation and function (7 papers). Eric Martel is often cited by papers focused on Cardiac electrophysiology and arrhythmias (16 papers), Heart Rate Variability and Autonomic Control (11 papers) and Ion channel regulation and function (7 papers). Eric Martel collaborates with scholars based in France, Germany and United Kingdom. Eric Martel's co-authors include Serge Richard, Pascal Champéroux, Marc Vandamme, Alain Le Pape, Stéphanie Lerondel, Delphine Riès, Éric Robert, Valérie Trichet, Laura Brullé and Jean‐Yves Le Guennec and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Applied Physiology.

In The Last Decade

Eric Martel

38 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Martel France 13 222 220 207 84 84 39 676
Donglin Guo China 26 976 4.4× 71 0.3× 810 3.9× 99 1.2× 19 0.2× 60 1.4k
John M. Bond United States 10 253 1.1× 21 0.1× 112 0.5× 51 0.6× 23 0.3× 12 622
David Benoîst France 16 271 1.2× 81 0.4× 485 2.3× 35 0.4× 30 0.4× 41 886
W. Rouslin United States 23 988 4.5× 68 0.3× 158 0.8× 154 1.8× 96 1.1× 43 1.3k
Jocelyn W. Dow United Kingdom 13 345 1.6× 53 0.2× 299 1.4× 79 0.9× 24 0.3× 27 607
Chong Huang United States 18 92 0.4× 530 2.4× 63 0.3× 199 2.4× 30 0.4× 51 867
Christopher A. Johnson United States 14 441 2.0× 17 0.1× 93 0.4× 172 2.0× 14 0.2× 26 902
Keiko Masuda Japan 13 287 1.3× 67 0.3× 88 0.4× 70 0.8× 3 0.0× 36 560
Yoshitaka Maeno Japan 18 315 1.4× 31 0.1× 155 0.7× 39 0.5× 12 0.1× 44 784
Yasutoshi Ohta Japan 15 188 0.8× 281 1.3× 116 0.6× 53 0.6× 7 0.1× 72 748

Countries citing papers authored by Eric Martel

Since Specialization
Citations

This map shows the geographic impact of Eric Martel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Martel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Martel more than expected).

Fields of papers citing papers by Eric Martel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Martel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Martel. The network helps show where Eric Martel may publish in the future.

Co-authorship network of co-authors of Eric Martel

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Martel. A scholar is included among the top collaborators of Eric Martel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Martel. Eric Martel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zonghao, et al.. (2025). Bidirectional Endothelial Feedback Drives Turing-Vascular Patterning and Drug-Resistance Niches: A Hybrid PDE-Agent-Based Study. Bioengineering. 12(10). 1097–1097. 2 indexed citations
2.
Augustin, Robert, Anouk Oldenburger, Jens Markus Borghardt, et al.. (2025). Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide. Molecular Metabolism. 99. 102205–102205. 1 indexed citations
3.
Delpy, Eric, et al.. (2025). A comprehensive review of 20 years of progress in nonclinical QT evaluation and proarrhythmic assessment. Journal of Pharmacokinetics and Pharmacodynamics. 52(3). 32–32. 1 indexed citations
4.
Delaunois, Annie, Eric Delpy, Céline Posseme, et al.. (2024). Results from a Joined Prospective Study to Evaluate the Sensitivity of the In Vivo Dog QT Assay in Line with the ICH E14/S7B Q&A Best Practices. Clinical Pharmacology & Therapeutics. 116(1). 106–116. 5 indexed citations
5.
Trautmann, Thomas, et al.. (2023). Thirty years of telemetry-based data acquisition for cardiovascular drug safety evaluation: Applications and optimization. Journal of Pharmacological and Toxicological Methods. 122. 107279–107279. 2 indexed citations
6.
Wallman, Mikael, et al.. (2022). An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds. Journal of Pharmacological and Toxicological Methods. 115. 107171–107171. 3 indexed citations
7.
Wallman, Mikael, et al.. (2021). An Integrative Approach for Improved Assessment of Cardiovascular Safety Data. Journal of Pharmacology and Experimental Therapeutics. 377(2). 218–231. 3 indexed citations
8.
Guennec, Jean‐Yves Le, Jérôme Thireau, Julien Roussel, et al.. (2016). Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety?. Scientific Reports. 6(1). 37948–37948. 3 indexed citations
9.
Champéroux, Pascal, et al.. (2013). Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: Comparative study with beagle dogs. Journal of Pharmacological and Toxicological Methods. 68(1). 166–174. 9 indexed citations
10.
Brullé, Laura, Marc Vandamme, Delphine Riès, et al.. (2012). Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model. PLoS ONE. 7(12). e52653–e52653. 210 indexed citations
11.
Goupille, Caroline, Stéphan Chevalier, Justine Lebeau, et al.. (2011). Reducing endothelial NOS activation and interstitial fluid pressure with n –3 PUFA offset tumor chemoresistance. Carcinogenesis. 33(2). 260–267. 19 indexed citations
12.
Champéroux, Pascal, et al.. (2011). A step towards characterisation of electrophysiological profile of torsadogenic drugs. Journal of Pharmacological and Toxicological Methods. 63(3). 269–278. 17 indexed citations
13.
Guennec, J.-Y. Le, et al.. (2010). Cardioprotection by omega-3 fatty acids: Involvement of PKCs?. Prostaglandins Leukotrienes and Essential Fatty Acids. 82(4-6). 173–177. 8 indexed citations
14.
Champéroux, Pascal, et al.. (2010). Interferences of the autonomic nervous system with drug induced QT prolongation: A point to consider in non-clinical safety studies. Journal of Pharmacological and Toxicological Methods. 61(3). 251–263. 13 indexed citations
15.
Champéroux, Pascal, et al.. (2008). Calculation of QT shift in non clinical safety pharmacology studies. Journal of Pharmacological and Toxicological Methods. 59(2). 73–85. 15 indexed citations
16.
Martel, Eric, Pierre Besson, Charles Couet, et al.. (2007). Dietary long-chainn-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-δ and protein kinase-C-ε translocation. British Journal Of Nutrition. 98(6). 1143–1151. 27 indexed citations
17.
Bourrinet, Philippe, Eric Martel, Pascal Champéroux, et al.. (2007). Cardiovascular Safety of Gadoterate Meglumine (Gd-DOTA). Investigative Radiology. 42(2). 63–77. 19 indexed citations
18.
Champéroux, Pascal, et al.. (2005). Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres. British Journal of Pharmacology. 144(3). 376–385. 48 indexed citations
19.
Champéroux, Pascal, et al.. (2000). Hemodynamic effects of MF 10058, a new cardioselective muscarinic M2 receptor antagonist, in conscious dogs. European Journal of Pharmacology. 406(1). 93–98. 2 indexed citations
20.
Pouchelon, Jean‐Louis, Eric Martel, Pascal Champéroux, Serge Richard, & Jonathan N. King. (2000). Effects of clomipramine hydrochloride on heart rate and rhythm in healthy dogs. American Journal of Veterinary Research. 61(8). 960–964. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donglin Guo Breakdown of academic impact, for papers by John M. Bond Breakdown of academic impact, for papers by David Benoîst Breakdown of academic impact, for papers by W. Rouslin Breakdown of academic impact, for papers by Jocelyn W. Dow Breakdown of academic impact, for papers by Chong Huang Breakdown of academic impact, for papers by Christopher A. Johnson Breakdown of academic impact, for papers by Keiko Masuda Breakdown of academic impact, for papers by Yoshitaka Maeno Breakdown of academic impact, for papers by Yasutoshi Ohta
Rankless by CCL
2026